Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionRoyce & Associates Lp
ManagerChuck Royce
Latest Disclosed Ownership71,475 shares
Latest Disclosed Value $ 4,028,331
Royce & Associates Lp ownership in HAE / Haemonetics Corporation

On May 12, 2026 - Royce & Associates Lp filed a 13F-HR form disclosing ownership of 71,475 shares of Haemonetics Corporation (US:HAE) valued at $4,028,331 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 71,475 shares of Haemonetics Corporation. This represents a change in shares of 0.00% during the quarter. The current value of the position is $5,094,738 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 71,475 0 0.00 4,028 -29.68 0.0398
2026-02-09 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 71,475 -629,767 -89.81 5,729 -83.24 0.0581
2025-11-12 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 701,242 -569,815 -44.83 34,179 -63.96 0.3408
2025-08-11 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,271,057 109,761 9.45 94,834 28.50 0.9733
2025-05-06 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,161,296 8,028 0.70 73,800 -18.04 0.7999
2025-02-10 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,153,268 -57,278 -4.73 90,047 -7.46 0.8354
2024-11-06 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,210,546 30,868 2.62 97,304 -0.30 0.8845
2024-08-13 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,179,678 -86,936 -6.86 97,595 -9.72 0.9123
2024-05-13 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,266,614 300,259 31.07 108,106 30.83 0.9649
2024-02-12 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 966,355 18,805 1.98 82,633 -2.65 0.7632
2023-11-09 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 947,550 41,258 4.55 84,882 10.01 0.8644
2023-08-07 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 906,292 62,538 7.41 77,162 10.51 0.7491
2023-05-23 2023-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 843,754 18,292 2.22 69,821 7.54 0.6988
2023-05-04 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 843,754 18,292 70 0.6989
2023-05-23 2022-12-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 825,462 -49,346 -5.64 64,923 0.25 0.6823
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 825,462 -49,346 65 0.6786
2022-11-03 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 874,808 33,223 3.95 64,762 18.06 0.7324
2022-08-04 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 841,585 84,341 11.14 54,855 14.58 0.5647
2022-05-05 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 757,244 49,136 6.94 47,873 27.46 0.4066
2022-02-07 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 708,108 -276,250 -28.06 37,558 -45.95 0.2806
2021-11-10 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 984,358 382,812 63.64 69,486 73.34 0.5197
2021-08-06 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 601,546 132,961 28.38 40,087 -22.94 0.2755
2021-05-10 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 468,585 -130,171 -21.74 52,018 -26.84 0.3497
2021-02-08 2020-12-31 13F HAEMONETICS COM 405024100 598,756 15,148 2.60 71,102 39.63 0.5875
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 583,608 90,415 18.33 50,920 15.28 0.5496
2020-08-07 2020-06-30 13F HAEMONETICS COM 405024100 493,193 116,588 30.96 44,170 17.69 0.4865
2020-05-12 2020-03-31 13F HAEMONETICS COM 405024100 376,605 346,436 1,148.32 37,532 982.86 0.5114
2020-02-06 2019-12-31 13F HAEMONETICS COM 405024100 30,169 30,169 3,466 0.0310
2018-11-13 2018-09-30 13F HAEMONETICS COM 405024100 0 -19,300 -100.00 0 -100.00
2018-08-09 2018-06-30 13F HAEMONETICS COM 405024100 19,300 -700 -3.50 1,731 18.32 0.0120
2018-05-14 2018-03-31 13F HAEMONETICS COM 405024100 20,000 19,792 9,515.38 1,463 12,091.67 0.0102
2018-02-09 2017-12-31 13F HAEMONETICS COM 405024100 208 -41 -16.47 12 9.09 0.0001
2017-11-13 2017-09-30 13F HAEMONETICS COM 405024100 249 -223,851 -99.89 11 -99.88 0.0001
2013-11-12 2013-09-30 13F HAEMONETICS COM 405024100 224,100 -103,900 -31.68 8,937 -34.11 0.0266
2013-08-07 2013-06-30 13F HAEMONETICS COM 405024100 328,000 328,000 13,563 0.0419
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.